Sargent Investment Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,000
| Closed | -$28.2K | – | 221 |
|
|
2024
Q2 | $28.2K | Sell |
1,000
-80
| -7% | -$2.25K | 0.01% | 218 |
|
|
2024
Q1 | $324K | Buy |
1,080
+500
| +86% | +$150K | 0.07% | 147 |
|
|
2023
Q4 | $137K | Hold |
580
| – | – | 0.03% | 200 |
|
|
2023
Q3 | $87K | Sell |
580
-500
| -46% | -$75K | 0.02% | 195 |
|
|
2023
Q2 | $188K | Hold |
1,080
| – | – | 0.05% | 186 |
|
|
2023
Q1 | $135K | Buy |
+1,080
| New | +$135K | 0.04% | 188 |
|